<SEC-DOCUMENT>0001564590-19-045994.txt : 20200323
<SEC-HEADER>0001564590-19-045994.hdr.sgml : 20200323
<ACCEPTANCE-DATETIME>20191213193156
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001564590-19-045994
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20191213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FIBROGEN INC
		CENTRAL INDEX KEY:			0000921299
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		409 ILLINOIS STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
		BUSINESS PHONE:		415-978-1200

	MAIL ADDRESS:	
		STREET 1:		409 ILLINOIS STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
fgen-corresp.htm
</title>
</head>
<!-- NG Converter v5.0.19273.161 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glxlclewy5uo000001.jpg" title="" alt="" style="width:834px;height:122px;"></p>
<p style="text-align:right;margin-bottom:12pt;margin-top:18pt;line-height:15pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">VIA EDGAR </p>
<p style="margin-bottom:12pt;margin-top:18pt;line-height:15pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 13, 2019</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Securities and Exchange Commission</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Division of Corporation Finance</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Office of Life Sciences</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100 F Street, N.E. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attn: <font style="margin-left:36pt;">Sasha Parikh</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.76%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;Rolf Sundwall</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.76%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-size:11pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:11pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">RE:</font></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:11pt;">FibroGen, Inc.<br />Form 10-K for the Year Ended December 31, 2018<br />Filed February 27, 2019</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:4.76%;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">File No. 001-36740<br /></p>
<p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ladies and Gentlemen:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="zzmpFIXED_FirmName"></a>FibroGen, Inc. (&#8220;<font style="font-weight:bold;font-style:italic;">FibroGen</font>&#8221; or the &#8220;<font style="font-weight:bold;font-style:italic;">Company</font>&#8221; or &#8220;<font style="font-weight:bold;">we</font>&#8221;) is submitting this letter via electronic submission in response to a letter (the &#8220;<font style="font-weight:bold;font-style:italic;">Comment Letter</font>&#8221;), dated December 3, 2019, from the Division of Corporation Finance, Office of Life Sciences, of the Securities and Exchange Commission (the &#8220;<font style="font-weight:bold;font-style:italic;">Commission</font>&#8221;) with respect to the Company&#8217;s Form 10-K for the year ending December 31, 2018 (the &#8220;<font style="font-weight:bold;font-style:italic;">2018 10-K</font>&#8221;), filed on February 27, 2019.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the Commission&#8217;s convenience, we have incorporated your comments into this response letter in italics. Capitalized terms used in this letter but otherwise not defined herein shall have the meanings ascribed to such terms in the 2018 10-K. </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">ITEM 1. BUSINESS</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">PAMREVLUMAB FOR THE TREATMENT OF FIBROSIS AND CANCER</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Clinical Development of Pamrevlumab, page 28</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-weight:bold;font-style:italic;font-size:11pt;font-family:Arial;text-transform:none;font-variant: normal;">1. <font style="font-weight:normal;">Please address the following regarding your disclosure of certain serious adverse events (SAEs) experienced by patients in the clinical development of Pamrevlumab:</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;"><font style="font-style:italic;font-family:Arial;">You disclose on page 31 that there have been 45 SAEs in 31 patients, four of which were considered possibly related by the principal investigator to study treatment.</font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glxlclewy5uo000002.jpg" title="" alt="" style="width:814px;height:58px;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glxlclewy5uo000001.jpg" title="" alt="" style="width:834px;height:122px;"></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-style:italic;font-family:Arial;">Further, on page 34, you disclose that there were 99 TSAEs; si</font><font style="font-style:italic;font-family:Arial;">x of which were assessed as possibly related by the principal investigator, and 93 as not related to study treatment.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-style:italic;font-size:11pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Please provide us proposed disclosure to be provided in future filings identifying each treatment related SAE "possibly" related to Pamrevlumab.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Response:<font style="font-weight:normal;"> </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company acknowledges the Commission&#8217;s comment but we believe that the particular serious adverse events (&#8220;<font style="font-weight:bold;font-style:italic;">SAEs</font>&#8221;) that a principal investigator cannot rule out as unrelated to the study drug (i.e. &#8220;possibly related to study treatment&#8221;) are not material to an investor&#8217;s decision to buy or sell the Company&#8217;s stock as discussed below. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to U.S. Food and Drug Administration (&#8220;<font style="font-weight:bold;font-style:italic;">FDA</font>&#8221;) regulations, clinical study sponsors do not report to the FDA SAEs deemed by a principal investigator to be possibly related to a study drug. Such a designation by the investigator did not lead to modification of the drug administration during the study, does not necessarily affect the safety of the drug or whether a clinical study is allowed to continue by the FDA, or even the chances of U.S. regulatory approval of the study drug. Upon evaluation of these events, there was no evidence of a causal relationship between the drug and these adverse events. The Company therefore feels that disclosing these events would not help, and could confuse, an investor&#8217;s understanding of the value of the product candidate and the results of the Company&#8217;s clinical development. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In contrast, we believe the more relevant and informative disclosure is regarding whether there have been any safety signals discovered during a clinical trial or other unusual or material safety issues. Therefore, the Company proposes to modify the applicable language in the Company&#8217;s next Form 10-K for the year-ending 2019 to the following:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:11pt;font-family:Arial;text-transform:none;font-variant: normal;">Page 31 - Study 049 &#8211; Open-label Phase 2 trial of pamrevlumab in idiopathic pulmonary fibrosis (&#8220;IPF&#8221;)</p>
<p style="margin-top:13pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Eighty-nine patients had at least one adverse event. The most common reported events were cough, fatigue, shortness of breath, upper respiratory tract infection, sore throat, bronchitis, nausea, dizziness, and urinary tract infection. No safety signal was identified in this study and adverse events observed to date are consistent with typical conditions observed in this patient population.&#8221;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:11pt;font-family:Arial;text-transform:none;font-variant: normal;">Page 34 - Study 028 &#8211; Open-label dose finding trial of pamrevlumab combined with gemcitabine plus erlotinib in patients with previously untreated locally advanced (stage 3) or metastatic (stage 4) pancreatic cancer</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glxlclewy5uo000002.jpg" title="" alt="" style="width:814px;height:58px;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glxlclewy5uo000001.jpg" title="" alt="" style="width:834px;height:122px;"></p>
<p style="margin-top:13pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><font style="color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;In the study, the majority of adverse events were mild to moderate, and were consistent with those observed for erlotinib plus gemcitabine treatment wi</font><font style="color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">thout pamrevlumab. We did not identify any evolving dose-dependent pattern or safety signal, and higher doses of pamrevlumab were not associated with higher numbers of SAEs or greater severity of the SAEs observed.&#8221;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company would note that the two studies at issue are earlier-stage completed trials and the FDA has since allowed us to progress to more advanced clinical trials in each of these diseases and very sick patient populations, although we chose to study a slightly different patient population within pancreatic cancer.&nbsp;&nbsp;The IPF study (049) referenced on page 31 of our 2018 10-K was followed by a randomized, double-blind, placebo-controlled Phase 2 trial (067) of pamrevlumab in IPF (see page 30 of the 2018 10-K).&nbsp;&nbsp;The pancreatic cancer study (028) referenced on page 34 was followed by an <font style="color:#000000;">open-label, randomized Phase 1/2 trial (069) in patients with inoperable locally advanced pancreatic cancer (see page 33 </font>of the 2018 10-K).&nbsp;&nbsp;<font style="color:#000000;"> </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company believes its proposed revised disclosure is also consistent with the rest of (and the more recent) safety disclosures in the 2018 10-K.&nbsp;&nbsp;For example in the more recent IPF study (067), our safety disclosure on page 30 of the 2018 10-K is as follows:</p>
<p style="margin-top:13pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Pamrevlumab was well-tolerated in the placebo-controlled study. The TEAEs were comparable between the pamrevlumab and placebo arms and the adverse events in the pamrevlumab arm were consistent with the known safety profile of pamrevlumab.&#8221;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Commission will find similar safety language for our other clinical trials on pages 6, 7, 18 and 22 of the 2018 10-K:</p>
<p style="margin-top:13pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;The preliminary safety analyses of each of these three studies show an overall safety profile consistent with the results observed in prior roxadustat studies. The adverse events reported are consistent with those expected in these study populations with similar background diseases.&#8221;</p>
<p style="margin-top:13pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;The preliminary safety analysis for this trial shows an overall event profile consistent with the results seen in previous roxadustat studies in CKD patients with anemia.&#8221;</p>
<p style="margin-top:13pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Roxadustat was generally well tolerated and there were no safety signals observed in the China Phase 3 clinical trials, including through the 52-week safety extension periods.&#8221;</p>
<p style="margin-top:13pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Roxadustat was well tolerated in this study, and the safety profile of roxadustat was consistent with that observed in previous studies both in dialysis and non-dialysis patients.&#8221;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company appreciates the Commission&#8217;s comments on this topic and believes the proposed disclosures above will provide more relevant, informative and less confusing disclosure for investors.</p>
<p style="margin-top:13pt;margin-bottom:0pt;margin-left:7.69%;text-indent:7.69%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glxlclewy5uo000002.jpg" title="" alt="" style="width:814px;height:58px;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glxlclewy5uo000001.jpg" title="" alt="" style="width:834px;height:122px;"></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please contact me at (415) 978-1522 with any questions or further comments regarding our responses to the Commission&#8217;s comments.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sincerely,</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">/s/ John Alden</font><font style="text-decoration:underline;margin-left:36pt;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">John Alden</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President, Legal</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cc:</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:11pt;">Pat Cotroneo, FibroGen, Inc.<br />Michael Lowenstein, FibroGen, Inc.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Greg Vlahos, PricewaterhouseCoopers LLP</p>
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:7.69%;text-indent:-7.69%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glxlclewy5uo000002.jpg" title="" alt="" style="width:814px;height:58px;"></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>glxlclewy5uo000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 glxlclewy5uo000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %V"?8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@"M?:C9Z;"LM[<QP1LP16=L9)["K-8EVD^HZV=.O=(BF
MTI(Q,L[L&!D!X&/SXY_6ML  8 P!3:L9PDY-]@HHHI&@4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBF>;&)1$77S"NX)GDCUQZ4 /H
MHHH **** $(!!!&0>HKD;G1[_P +W,FH>'(O/L7)>ZTG/!]6A_NM_L]#^5=?
M61=.[^*]-A5B%2VGE<9Z\QJ/YFJB1.7*K^GXEC2-9L=<L5N[&7>F=K*1AHV[
MJP[$>E7ZYK5_#DZW[:UH$J6FJX_>HW^JNP/X9!Z^C=?Z6]!\1P:T)+>2)[/4
MK?BYLIOOQGU']Y?0BAKJBK]ROXTUW^PO#\DD38NISY4'J">K?@/UQ7'3Z3J7
M@G0=)UZU>8M!)OU.V4G$B/@<CU48'/0G-7U_XK'XAE_OZ9I'3T=\_P!6'XA:
M[^XMXKNVEMIXQ)#*A1T8<,I&"*T;Y$E]YPT5[>K*MT6D?U?WZ!:W,-[:0W5O
M()(9D#HXZ$$9!J6N$\$7$VA:M?>#;YRQM29["1O^6D+'./PSG\_2N@UWQ'#H
MYBM887O-4N.+>RB/S/\ [1_NJ.Y/I6;CK9'<GH6]8UJQT*Q-U?2[5SM1%&7D
M;LJCN36!;:+?>)KF/4?$D?E6:,'M=)SE5]&F_O-_L]!^=6]'\.3?;5UK7I4O
M-7(^0 ?NK4'^&,?^S=3_ #N:*[#4-;@=BQCO0RY/16B0@?SI[+0B4K-)]37
M   & .@I:**@T*.L-?+I<W]FR0I>' B,WW<DCCZ^GO5BT$ZV<(N?+\\(!)Y?
MW=V.<>V:XCQF[:IXMT#0XV./,^T2@'MG^8"M^==[5M6BCGI5.>K.VT;+]0HH
MHJ#H"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA)+K>C[IIY(5#+##@Y$A]?;TW>M=1X,T_3UTF/6()WO;O4$$D][-_K'/=?\
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M^)(_J/ZCBMBL6FMS0****0!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCKNOA)_R/,?_ %[R?TKA:[KX2?\ (\Q_]>\G]*Z9_"S&.Y[[1117$= 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MSWB[Q=9>$]-\Z;$EU("(+<'ESZGT4=S6GK&JVVB:3<:C>-MA@3<<=6/8#W)P
M*^:=?UR\\1:O-J-Z^7D.%0'Y8U[*/8?_ %ZUIT^9Z[$3E836]=U#Q!J#7NHS
MF60\*O14'HH["LVBG1QO+(L<:,[L<*JC))] *Z]C$;17K'A7X1>;''>>(G9
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MZ?7%15BFKL<&TSWJBBBN0W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#-U+2GU"]L+A;ZXMQ:2F0QQ'B7V;_/
M<U'9ZO.\NH'4K/\ L^WMI=D<\T@"RK_>R<?Y/UK6JKJ&GVVJV$ME>1^9!*,,
MN<=\C]15)]&92@TW*&_YZ?UL6(Y$EC62-U=&&593D$>QIU>?2>%_$'A:1KCP
MS>M<VV<M9SX__4?J,&AOB3)]@G@.F_9];3"I!</LB9B0"2QQMP,G!QTQFJ]F
MWK'4PCC$GRUERO\ !^C.[NKNWL;9[FZGC@@09:21@JC\37!ZIXJN?%T5SHWA
MC2?MUO(#%/>W2E8%'MZGN._H#4UGX(NM<FCU+Q?J)OV^_'90-MMX_P NO^<D
MUW$%O#:P)!;PQPPH,*D:A54>P%+2/F=6K/+M%\*VVF>*(+'Q<SZC/)$HTZ>:
M1F@.T?-'M/\ $.P/!&. :]0EBA:UDAE51 4*LIX&W&"/IBJ>MZ-:Z[IDEE=!
M@#\T<B'#Q./NNI[$&N$M-4U'Q5?_ /"(7EW"JVA87]U!)S>(I "ICIG/S?C]
M*?QZA\.AC^$HO[8MK_1+F_C?0-$EDG"J?^/H;F*Y/=!@MCOD5O\ PLTYC#>:
MO,,L^+>(G^ZH&?\ V4?A69\0=/?P_JL-YIBK!;W]B;&:-!@84KC\UP/HM=_X
M2M8[3PEI<<0P&MTD/U<;C^IK23]RZZG TJF,C%_85_F]OP-FBBBN<]$****
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M[%;@]>&!%=!_PL[QA_T&/_):'_XBLZE-R=T5&:2L?1-%?.W_  L[QA_T&/\
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M5=5/X48R^(UK3Q'J-CH%UHUM+Y5M=2!YBN=S#&-N?0]_7Z5DT5[!X%^&%O\
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M4<=^:FJG8:78Z6)A96Z0^=(9)-O\3&KE2[=#>/-;WMSP+XM_\CS)_P!>\?\
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M]SC[O 'K@_A6!176U=6,5H?0G_"U/"7_ #_R_P#@._\ A1_PM3PE_P _\O\
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M2C3"<1F[F;CB*SF;K]%Q7&?VPNC?$QKR.PO_ ++K-OL,30&-GF3NH;&>,?\
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MN=U\)/\ D>8_^O>3^E>^UX%\)/\ D>8_^O>3^E>^USUOB-:>P4445D6%%%%
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MSA\1Z[1117&;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS[D<D3R&U^"<A<&[UM0H/*Q6^2?Q)X_*NNT;X9^&]'993:M>SKR'NCN _P"
M\+^E=A12=23ZC44A  H    X %+114%!1110 4444 %5K[3K+4[8V]]:PW,)
M_@E0,/KSWJS10!Y]J?PA\/WC%[.2YL6/\*-O3\FY_6N;N?@I?JW^BZQ;2#_I
MK$R?RS7LM%:*K)=27")X;_PIGQ%_S^Z7_P!_9/\ XBI(O@OKA/[[4-.09_@9
MV_FHKVZBG[:0O9Q/)K/X)Q@@WNM.P[K! %_4D_RKKM(^'/AG1V61+#[3,O22
MZ/F'ZX^[G\*ZNBI=23W8U%(.@P****@H**** "F30Q7$+PSQ)+$XPR.H96'H
M0:?10!PNK_"CP[J3-);+-82GG]PV4_[Y.?TQ7*W7P4O58_9-9@D7/'FQ%#^A
M->R45:J274EP3/#A\&?$.[F]TO&>OF2?_$5H6GP4N6(-YK,2#N(82V?Q)%>P
MT57MIBY(G$Z1\+/#6F,LDT,E_*O.;ELKG_=& ?QS79Q11P1+%%&L<:#"H@P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU!R5)'1,_P!3^@%=I-#'<0O#-&LD3@JZ.,A@>Q%$,,=O!'!"@2.-0B*.@ X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2-G:=N-V.,]*6B@
M#*T./4C;O<:S;VD=^S%=T'.8P<J"?Q/&?US6K113;NR81Y8VW"BBBD4%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
I44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>glxlclewy5uo000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 glxlclewy5uo000002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "V"?8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJ2ZQICZA_9ZZC9M>Y(
M^S"=?,R!D_+G/3FB^UC3-,=$O]1L[1G&5$\ZQEA[9/-.S"Z+M%%%( HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*HW6M:58S"&\U.SMY3T2:=4/Y$U=5E=0RD,I&00>"* %HJE?:QIFF.B7^HV=
MHSC*B>=8RP]LGFKM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$(A)&#_LC((^F:B+CR\K*DG?F1S/Q,U&/Q3XPTS1=+D6<P_NMR'<OF.PST]
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M2?SKI_%OAS_A*- ?2_M7V7<ZOYGE[\8.<8R/YU#FN9:C479Z&9\+E ^'>ED
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#RK5?A-J"ZK-J.AZ])%-*S.?/9E<$G)^=>
M3S[?G4,/PGUO4[J.3Q)XA,\:'HDCS,1Z!GQC\C7K=%:>UD1[.)7L;*WTVQ@L
MK2,1V\"!(T'8"K%%%9EA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
